Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Myelodysplasia: battle in the bone marrow. Nature medicine. . NIHMSID: NIHMS607880.
Progress in determining response to treatment in gastrointestinal stromal tumor. Expert review of anticancer therapy. . NIHMSID: NIHMS1628621.
Hypoxia-driven oncometabolite L-2HG maintains stemness-differentiation balance and facilitates immune evasion in pancreatic cancer. Cancer research. . NIHMSID: NIHMS1727368.
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer. Gastroenterology. . NIHMSID: NIHMS1893587.
46213 Florida Community-Engaged Research Alliance Against COVID-19 in Disproportionately Affected Communities (FL-CEAL): addressing education, awareness, access, and inclusion of underserved communities in COVID-19 research. Journal of clinical and translational science. . NIHMSID: NIHMS1895855.doi: 10.1017/cts.2021.609.
All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy. Bioconjugate chemistry. . NIHMSID: NIHMS1968905.
Rossi EC, Nimer S, Louis G. Inhibition of platelet aggregation by 5-nitro-2-furaldehyde diacetate with observations on structure-activity relationships. J Lab Clin Med. 1976 Apr;87(4):703-9. PubMed PMID: 1270881.
Chan JY, Slamon DJ, Nimer SD, Golde DW, Gasson JC. Regulation of expression of human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8669-73. doi: 10.1073/pnas.83.22.8669. PubMed PMID: 3490669; PubMed Central PMCID: PMC386992.
Nimer SD, Golde DW. The 5q- abnormality. Blood. 1987 Dec;70(6):1705-12. Review. PubMed PMID: 3315038.
Nimer SD, Gasson JC, DiPersio JF. The expression and target cell specificity of human granulocyte-macrophage colony-stimulating factor. Year Immunol. 1988;3:144-51. Review. PubMed PMID: 2831680.
Nimer SD, Morita EA, Martis MJ, Wachsman W, Gasson JC. Characterization of the human granulocyte-macrophage colony-stimulating factor promoter region by genetic analysis: correlation with DNase I footprinting. Mol Cell Biol. 1988 May;8(5):1979-84. doi: 10.1128/mcb.8.5.1979-1984.1988. PubMed PMID: 2838738; PubMed Central PMCID: PMC363376.
Nimer SD, Champlin RE, Golde DW. Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor. JAMA. 1988 Dec 9;260(22):3297-300. PubMed PMID: 3054191.
Champlin RE, Nimer SD, Ireland P, Oette DH, Golde DW. Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor. Blood. 1989 Feb 15;73(3):694-9. PubMed PMID: 2644986.
Nimer SD, Gasson JC, Hu K, Smalberg I, Williams JL, Chen IS, Rosenblatt JD. Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene. 1989 Jun;4(6):671-6. PubMed PMID: 2660069.
Nimer SD, Gates MJ, Koeffler HP, Gasson JC. Multiple mechanisms control the expression of granulocyte-macrophage colony-stimulating factor by human fibroblasts. J Immunol. 1989 Oct 1;143(7):2374-7. PubMed PMID: 2674282.
Gajewski JL, Ho WG, Nimer SD, Hirji KF, Gekelman L, Jacobs AD, Champlin RE. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J Clin Oncol. 1989 Nov;7(11):1637-45. doi: 10.1200/JCO.1989.7.11.1637. PubMed PMID: 2809680.
Champlin RE, Nimer SD, Oette D, Golde DW. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis. Prog Clin Biol Res. 1990;338:143-50. PubMed PMID: 2189137.
Gasson JC, Fraser JK, Nimer SD. Human granulocyte-macrophage colony-stimulating factor (GM-CSF): regulation of expression. Prog Clin Biol Res. 1990;338:27-41. Review. PubMed PMID: 2189139.
Nimer SD, Champlin RE. Therapeutic use of hematopoietic growth factors in bone marrow transplantation. Cancer Treat Res. 1990;50:141-64. doi: 10.1007/978-1-4613-1493-6_9. Review. PubMed PMID: 1976348.
Nimer SD, Milewicz AL, Champlin RE, Busuttil RW. Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation. 1990 Apr;49(4):819-21. PubMed PMID: 2326879.
Champlin RE, Ho WG, Nimer SD, Gajewski JG, Selch M, Burnison M, Holley G, Yam P, Petz L, Winston DJ. Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy. Transplantation. 1990 Apr;49(4):720-4. PubMed PMID: 2326866.
Champlin R, Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment. J Clin Oncol. 1990 Jul;8(7):1199-206. doi: 10.1200/JCO.1990.8.7.1199. PubMed PMID: 1694236.
Nimer S, Fraser J, Richards J, Lynch M, Gasson J. The repeated sequence CATT(A/T) is required for granulocyte-macrophage colony-stimulating factor promoter activity. Mol Cell Biol. 1990 Nov;10(11):6084-8. doi: 10.1128/mcb.10.11.6084-6088.1990. PubMed PMID: 2233734; PubMed Central PMCID: PMC361411.
Champlin R, Jansen J, Ho W, Gajewski J, Nimer S, Lee K, Territo M, Winston D, Tricot G, Reichert T. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia. Transplant Proc. 1991 Feb;23(1 Pt 2):1695-6. PubMed PMID: 1899162.
Nissenson AR, Nimer SD, Wolcott DL. Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects. Ann Intern Med. 1991 Mar 1;114(5):402-16. doi: 10.7326/0003-4819-114-5-402. Review. PubMed PMID: 1992884.
Schiller GJ, Nimer SD, Gajewski JL, Golde DW. Abdominal presentation of varicella-zoster infection in recipients of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1991 Jun;7(6):489-91. PubMed PMID: 1843181.
Nimer SD, Golde DW, Kwan K, Lee K, Clark S, Champlin R. In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin. Blood. 1991 Jul 1;78(1):163-8. PubMed PMID: 2070050.
Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol. 1992 Jan;10(1):41-6. doi: 10.1200/JCO.1992.10.1.41. PubMed PMID: 1727924.
Sawyers CL, Golde DW, Quan S, Nimer SD. Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia. Cancer. 1992 Mar 15;69(6):1342-6. doi: 10.1002/1097-0142(19920315)69:6<1342::aid-cncr2820690607>3.0.co;2-u. PubMed PMID: 1540871.
Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin R. A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia. Br J Haematol. 1992 Jun;81(2):170-7. doi: 10.1111/j.1365-2141.1992.tb08203.x. PubMed PMID: 1643014.
Nimer SD. The use of colony-stimulating factors in primary hematologic disorders. Cancer. 1992 Aug 15;70(4 Suppl):921-7. Review. PubMed PMID: 1638464.
Sakamoto KM, Nimer SD, Rosenblatt JD, Gasson JC. HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences. Oncogene. 1992 Nov;7(11):2125-30. PubMed PMID: 1359492.
Nichols J, Nimer SD. Transcription factors, translocations, and leukemia. Blood. 1992 Dec 15;80(12):2953-63. Review. PubMed PMID: 1361370.
Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, Champlin R. Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood. 1992 Dec 15;80(12):2977-82. PubMed PMID: 1467513.
Schiller G, Lee M, Territo M, Gajewski J, Nimer S. Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia. Am J Hematol. 1993 Jul;43(3):195-9. doi: 10.1002/ajh.2830430307. PubMed PMID: 8352235.
Chap L, Schiller G, Nimer SD. Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia. Bone Marrow Transplant. 1993 Aug;12(2):173-5. PubMed PMID: 8401368.
Schiller G, Nimer S, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study. Leuk Lymphoma. 1993 Sep;11(1-2):69-77. doi: 10.3109/10428199309054732. PubMed PMID: 8220156.
Nimer SD, Giorgi J, Gajewski JL, Ku N, Schiller GJ, Lee K, Territo M, Ho W, Feig S, Selch M. Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial. Transplantation. 1994 Jan;57(1):82-7. doi: 10.1097/00007890-199401000-00015. PubMed PMID: 8291119.
Chap L, Nimer SD. Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X. Leuk Lymphoma. 1994 Jan;12(3-4):315-6. doi: 10.3109/10428199409059604. PubMed PMID: 8167563.
Fraser JK, Guerra JJ, Nguyen CY, Indes JE, Gasson JC, Nimer SD. Characterization of a cell-type-restricted negative regulatory activity of the human granulocyte-macrophage colony-stimulating factor gene. Mol Cell Biol. 1994 Mar;14(3):2213-21. doi: 10.1128/mcb.14.3.2213-2221.1994. PubMed PMID: 8114751; PubMed Central PMCID: PMC358581.
Schiller G, Nimer S, Vescio R, Lieb G, Lee M, Gajewski J, Territo M, Berenson J. Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma. Bone Marrow Transplant. 1994 Jul;14(1):131-6. PubMed PMID: 7951100.
Nimer SD, Paquette RL, Ireland P, Resta D, Young D, Golde DW. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Exp Hematol. 1994 Aug;22(9):875-80. PubMed PMID: 8062886.
Nimer SD, Ireland P, Meshkinpour A, Frane M. An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood. 1994 Aug 1;84(3):923-7. PubMed PMID: 8043874.
Schiller G, Feig SA, Territo M, Wolin M, Lill M, Belin T, Hunt L, Nimer S, Champlin R, Gajewski J. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors. Br J Haematol. 1994 Sep;88(1):72-8. doi: 10.1111/j.1365-2141.1994.tb04979.x. PubMed PMID: 7803259.
Nimer SD, Leung DH, Wolin MJ, Golde DW. Serum stem cell factor levels in patients with aplastic anemia. Int J Hematol. 1994 Oct;60(3):185-9. PubMed PMID: 7532030.
Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Greene G, Nimer SD. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 1995;4(4-5):281-99. PubMed PMID: 7787419; PubMed Central PMCID: PMC6134382.
Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, Nimer SD. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995 Jan 1;85(1):283-90. PubMed PMID: 7803802.
Gordon MS, Nemunaitis J, Hoffman R, Paquette RL, Rosenfeld C, Manfreda S, Isaacs R, Nimer SD. A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood. 1995 Jun 1;85(11):3066-76. PubMed PMID: 7538815.
What would you like to do?